Annual SG&A
$21.14 M
+$8.06 M+61.67%
31 December 2023
Summary:
AIM ImmunoTech annual selling, general & administrative expenses is currently $21.14 million, with the most recent change of +$8.06 million (+61.67%) on 31 December 2023. During the last 3 years, it has risen by +$12.48 million (+144.25%). AIM annual SG&A is now at all-time high.AIM Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.08 M
+$488.00 K+18.83%
30 September 2024
Summary:
AIM ImmunoTech quarterly selling, general & administrative expenses is currently $3.08 million, with the most recent change of +$488.00 thousand (+18.83%) on 30 September 2024. Over the past year, it has dropped by -$2.36 million (-43.39%). AIM quarterly SG&A is now -71.64% below its all-time high of $10.86 million, reached on 31 December 2023.AIM Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.66 B
-$23.93 M-1.46%
30 September 2024
Summary:
AIM ImmunoTech TTM selling, general & administrative expenses is currently -$1.66 billion, with the most recent change of -$23.93 million (-1.46%) on 30 September 2024. Over the past year, it has dropped by -$1.68 billion (-12161.91%). AIM TTM SG&A is now -3722.66% below its all-time high of $22.70 million, reached on 30 June 2024.AIM TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.7% | -43.4% | -10000.0% |
| 3 y3 years | +144.3% | +71.2% | -10000.0% |
| 5 y5 years | +240.9% | +66.8% | -10000.0% |
AIM Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +144.3% | -71.6% | +71.2% | -19.3% | at low |
| 5 y | 5 years | at high | +240.9% | -71.6% | +107.5% | -28.8% | at low |
| alltime | all time | at high | +949.0% | -71.6% | +812.7% | -3722.7% | at low |
AIM ImmunoTech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.08 M(+18.8%) | $20.34 M(-10.4%) |
| June 2024 | - | $2.59 M(-32.1%) | $22.70 M(+0.2%) |
| Mar 2024 | - | $3.81 M(-64.9%) | $22.66 M(+7.2%) |
| Dec 2023 | $21.14 M(+61.7%) | $10.86 M(+99.6%) | $21.14 M(+53.3%) |
| Sept 2023 | - | $5.44 M(+113.3%) | $13.79 M(+2.0%) |
| June 2023 | - | $2.55 M(+11.3%) | $13.52 M(+2.8%) |
| Mar 2023 | - | $2.29 M(-34.6%) | $13.15 M(+1.7%) |
| Dec 2022 | $13.07 M(+50.8%) | $3.50 M(-32.2%) | $12.93 M(+7.4%) |
| Sept 2022 | - | $5.17 M(+137.0%) | $12.04 M(+38.9%) |
| June 2022 | - | $2.18 M(+5.3%) | $8.67 M(+0.4%) |
| Mar 2022 | - | $2.07 M(-20.8%) | $8.63 M(-0.5%) |
| Dec 2021 | $8.67 M(+0.2%) | $2.62 M(+45.5%) | $8.67 M(+0.4%) |
| Sept 2021 | - | $1.80 M(-16.1%) | $8.64 M(-3.2%) |
| June 2021 | - | $2.15 M(+1.6%) | $8.93 M(+5.0%) |
| Mar 2021 | - | $2.11 M(-18.3%) | $8.50 M(-1.8%) |
| Dec 2020 | $8.65 M(+22.9%) | $2.58 M(+23.9%) | $8.65 M(+14.6%) |
| Sept 2020 | - | $2.08 M(+21.4%) | $7.55 M(+3.3%) |
| June 2020 | - | $1.72 M(-24.3%) | $7.32 M(-3.0%) |
| Mar 2020 | - | $2.27 M(+52.8%) | $7.54 M(+7.1%) |
| Dec 2019 | $7.04 M(+13.5%) | $1.48 M(-19.6%) | $7.04 M(-2.1%) |
| Sept 2019 | - | $1.85 M(-4.9%) | $7.19 M(+8.7%) |
| June 2019 | - | $1.94 M(+9.9%) | $6.61 M(+3.3%) |
| Mar 2019 | - | $1.77 M(+8.3%) | $6.41 M(+3.3%) |
| Dec 2018 | $6.20 M(-5.6%) | $1.63 M(+28.2%) | $6.20 M(-1.6%) |
| Sept 2018 | - | $1.27 M(-26.5%) | $6.30 M(-4.3%) |
| June 2018 | - | $1.73 M(+10.9%) | $6.58 M(+1.8%) |
| Mar 2018 | - | $1.56 M(-9.8%) | $6.47 M(-1.5%) |
| Dec 2017 | $6.57 M(-14.4%) | $1.73 M(+11.4%) | $6.57 M(-3.3%) |
| Sept 2017 | - | $1.56 M(-3.9%) | $6.80 M(-1.1%) |
| June 2017 | - | $1.62 M(-2.7%) | $6.88 M(-0.3%) |
| Mar 2017 | - | $1.66 M(-15.1%) | $6.90 M(-10.2%) |
| Dec 2016 | $7.68 M(+7.5%) | $1.96 M(+20.0%) | $7.68 M(+5.7%) |
| Sept 2016 | - | $1.63 M(-0.3%) | $7.27 M(-0.7%) |
| June 2016 | - | $1.64 M(-33.0%) | $7.32 M(-4.7%) |
| Mar 2016 | - | $2.45 M(+58.2%) | $7.68 M(+7.5%) |
| Dec 2015 | $7.15 M(-21.1%) | $1.55 M(-8.2%) | $7.15 M(-4.0%) |
| Sept 2015 | - | $1.69 M(-15.8%) | $7.45 M(-6.2%) |
| June 2015 | - | $2.00 M(+4.7%) | $7.94 M(-5.9%) |
| Mar 2015 | - | $1.91 M(+3.6%) | $8.43 M(-6.9%) |
| Dec 2014 | $9.06 M(+17.3%) | $1.85 M(-15.0%) | $9.06 M(+1.0%) |
| Sept 2014 | - | $2.17 M(-12.9%) | $8.97 M(+1.2%) |
| June 2014 | - | $2.50 M(-1.7%) | $8.87 M(+8.3%) |
| Mar 2014 | - | $2.54 M(+44.3%) | $8.19 M(+6.0%) |
| Dec 2013 | $7.72 M(-14.7%) | $1.76 M(-15.0%) | $7.72 M(-20.8%) |
| Sept 2013 | - | $2.07 M(+13.9%) | $9.75 M(+4.4%) |
| June 2013 | - | $1.82 M(-12.5%) | $9.34 M(+0.9%) |
| Mar 2013 | - | $2.08 M(-45.1%) | $9.26 M(+2.2%) |
| Dec 2012 | $9.06 M(+35.3%) | $3.79 M(+128.1%) | $9.06 M(+28.1%) |
| Sept 2012 | - | $1.66 M(-4.5%) | $7.07 M(+0.3%) |
| June 2012 | - | $1.74 M(-7.3%) | $7.05 M(+4.2%) |
| Mar 2012 | - | $1.87 M(+4.1%) | $6.77 M(+1.1%) |
| Dec 2011 | $6.69 M(-11.6%) | $1.80 M(+10.2%) | $6.69 M(-3.9%) |
| Sept 2011 | - | $1.64 M(+12.3%) | $6.96 M(-1.5%) |
| June 2011 | - | $1.46 M(-19.1%) | $7.07 M(-4.5%) |
| Mar 2011 | - | $1.80 M(-13.2%) | $7.40 M(-2.2%) |
| Dec 2010 | $7.57 M | $2.07 M(+19.3%) | $7.57 M(+6.6%) |
| Sept 2010 | - | $1.74 M(-2.8%) | $7.10 M(+8.8%) |
| June 2010 | - | $1.79 M(-9.2%) | $6.53 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $1.97 M(+22.8%) | $6.60 M(+13.9%) |
| Dec 2009 | $5.80 M(-10.5%) | $1.60 M(+37.8%) | $5.80 M(+9.2%) |
| Sept 2009 | - | $1.16 M(-37.5%) | $5.31 M(-8.8%) |
| June 2009 | - | $1.86 M(+59.7%) | $5.82 M(+1.3%) |
| Mar 2009 | - | $1.17 M(+4.5%) | $5.75 M(-11.3%) |
| Dec 2008 | $6.48 M(-27.8%) | $1.12 M(-33.4%) | $6.48 M(-13.6%) |
| Sept 2008 | - | $1.68 M(-6.4%) | $7.50 M(-19.6%) |
| June 2008 | - | $1.79 M(-5.6%) | $9.34 M(+2.7%) |
| Mar 2008 | - | $1.90 M(-11.4%) | $9.09 M(+1.3%) |
| Dec 2007 | $8.97 M(+9.1%) | $2.14 M(-39.0%) | $8.97 M(+4.3%) |
| Sept 2007 | - | $3.51 M(+127.3%) | $8.61 M(+35.0%) |
| June 2007 | - | $1.54 M(-13.5%) | $6.37 M(-7.9%) |
| Mar 2007 | - | $1.78 M(+0.7%) | $6.92 M(-15.9%) |
| Dec 2006 | $8.22 M(+52.6%) | $1.77 M(+38.8%) | $8.23 M(+4.0%) |
| Sept 2006 | - | $1.28 M(-38.8%) | $7.91 M(-1.3%) |
| June 2006 | - | $2.09 M(-32.6%) | $8.02 M(+7.6%) |
| Mar 2006 | - | $3.09 M(+112.4%) | $7.46 M(+38.3%) |
| Dec 2005 | $5.39 M(-12.6%) | $1.46 M(+5.2%) | $5.39 M(+10.7%) |
| Sept 2005 | - | $1.38 M(-9.1%) | $4.87 M(+1.8%) |
| June 2005 | - | $1.52 M(+48.3%) | $4.78 M(+10.3%) |
| Mar 2005 | - | $1.03 M(+9.8%) | $4.34 M(-29.5%) |
| Dec 2004 | $6.16 M(+44.8%) | $935.00 K(-28.0%) | $6.15 M(-11.1%) |
| Sept 2004 | - | $1.30 M(+20.7%) | $6.93 M(+3.8%) |
| June 2004 | - | $1.08 M(-62.2%) | $6.67 M(+3.7%) |
| Mar 2004 | - | $2.84 M(+66.6%) | $6.43 M(+51.1%) |
| Dec 2003 | $4.26 M(+111.3%) | $1.71 M(+63.3%) | $4.26 M(+101.0%) |
| Sept 2003 | - | $1.04 M(+24.7%) | $2.12 M(+15.1%) |
| June 2003 | - | $838.00 K(+25.6%) | $1.84 M(-0.7%) |
| Mar 2003 | - | $667.00 K(-254.4%) | $1.85 M(-8.0%) |
| Dec 2002 | $2.02 M(-40.9%) | -$432.00 K(-156.3%) | $2.02 M(-36.7%) |
| Sept 2002 | - | $767.00 K(-9.9%) | $3.18 M(+3.0%) |
| June 2002 | - | $851.00 K(+2.7%) | $3.09 M(-4.8%) |
| Mar 2002 | - | $829.00 K(+12.8%) | $3.24 M(-2.5%) |
| Dec 2001 | $3.41 M(-7.7%) | $735.00 K(+9.2%) | $3.33 M(-5.3%) |
| Sept 2001 | - | $673.00 K(-33.1%) | $3.51 M(-2.8%) |
| June 2001 | - | $1.01 M(+10.4%) | $3.61 M(+2.1%) |
| Mar 2001 | - | $911.00 K(-1.3%) | $3.54 M(0.0%) |
| Dec 2000 | $3.69 M(-57.6%) | $922.60 K(+19.4%) | $3.54 M(-50.4%) |
| Sept 2000 | - | $772.60 K(-17.0%) | $7.14 M(-4.4%) |
| June 2000 | - | $931.40 K(+2.2%) | $7.46 M(-7.1%) |
| Mar 2000 | - | $911.00 K(-79.8%) | $8.03 M(-7.9%) |
| Dec 1999 | $8.72 M(+190.7%) | $4.52 M(+311.0%) | $8.72 M(+78.0%) |
| Sept 1999 | - | $1.10 M(-26.7%) | $4.90 M(+6.5%) |
| June 1999 | - | $1.50 M(-6.3%) | $4.60 M(+21.1%) |
| Mar 1999 | - | $1.60 M(+128.6%) | $3.80 M(+26.7%) |
| Dec 1998 | $3.00 M(-14.3%) | $700.00 K(-12.5%) | $3.00 M(+3.4%) |
| Sept 1998 | - | $800.00 K(+14.3%) | $2.90 M(+3.6%) |
| June 1998 | - | $700.00 K(-12.5%) | $2.80 M(+7.7%) |
| Mar 1998 | - | $800.00 K(+33.3%) | $2.60 M(-27.8%) |
| Dec 1997 | $3.50 M(+16.7%) | $600.00 K(-14.3%) | $3.60 M(+2.9%) |
| Sept 1997 | - | $700.00 K(+40.0%) | $3.50 M(-14.6%) |
| June 1997 | - | $500.00 K(-72.2%) | $4.10 M(-4.7%) |
| Mar 1997 | - | $1.80 M(+260.0%) | $4.30 M(+43.3%) |
| Dec 1996 | $3.00 M(-25.0%) | $500.00 K(-61.5%) | $3.00 M(+20.0%) |
| Sept 1996 | - | $1.30 M(+85.7%) | $2.50 M(+108.3%) |
| June 1996 | - | $700.00 K(+40.0%) | $1.20 M(+140.0%) |
| Mar 1996 | - | $500.00 K | $500.00 K |
| Dec 1995 | $4.00 M | - | - |
FAQ
- What is AIM ImmunoTech annual selling, general & administrative expenses?
- What is the all time high annual SG&A for AIM ImmunoTech?
- What is AIM ImmunoTech annual SG&A year-on-year change?
- What is AIM ImmunoTech quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly SG&A year-on-year change?
- What is AIM ImmunoTech TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for AIM ImmunoTech?
- What is AIM ImmunoTech TTM SG&A year-on-year change?
What is AIM ImmunoTech annual selling, general & administrative expenses?
The current annual SG&A of AIM is $21.14 M
What is the all time high annual SG&A for AIM ImmunoTech?
AIM ImmunoTech all-time high annual selling, general & administrative expenses is $21.14 M
What is AIM ImmunoTech annual SG&A year-on-year change?
Over the past year, AIM annual selling, general & administrative expenses has changed by +$8.06 M (+61.67%)
What is AIM ImmunoTech quarterly selling, general & administrative expenses?
The current quarterly SG&A of AIM is $3.08 M
What is the all time high quarterly SG&A for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly selling, general & administrative expenses is $10.86 M
What is AIM ImmunoTech quarterly SG&A year-on-year change?
Over the past year, AIM quarterly selling, general & administrative expenses has changed by -$2.36 M (-43.39%)
What is AIM ImmunoTech TTM selling, general & administrative expenses?
The current TTM SG&A of AIM is -$1.66 B
What is the all time high TTM SG&A for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM selling, general & administrative expenses is $22.70 M
What is AIM ImmunoTech TTM SG&A year-on-year change?
Over the past year, AIM TTM selling, general & administrative expenses has changed by -$1.68 B (-12161.91%)